전체메뉴
Article Search

KJASEM The Korean Journal of Aerospace and Environmental Medicine

QR Code QR Code

Article Tools

Article

Review Article

코로나바이러스감염증-19 후유증과 항공안전

Long COVID and Aviation Safety

권영환

대한항공 항공의료센터

Young Hwan Kwon , M.D.

Aeromedical Center, Korean Air, Seoul, Korea

Correspondence to:
Young Hwan Kwon
Aeromedical Center, Korean Air, 260 Haneulgil, Gangseo-gu, Seoul 07505, Korea
Tel: +82-2-2656-7150
Fax: +82-2-2656-3848
E-mail: kumcim@naver.com
Received: August 30, 2022; Accepted: September 14, 2022

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Korean J Aerosp Environ Med 2022; 32(3): 80-84

Published December 31, 2022 https://doi.org/10.46246/KJAsEM.220019

Copyright © Aerospace Medical Association of Korea.

Abstract

Go to
Since its emergence in Wuhan, China, COVID-19 has spread and had a profound effect on the lives and health of people around the globe. Most people who develop COVID-19 fully recover, but current evidence suggests approximately 10% to 20% of people experience a variety of mid- and long-term effects after they recover from their initial illness. These mid- and long-term effects are collectively known as post covid-19 condition or “long COVID”. Studies have shown that a significant number of patients complain of multiple symptoms over a period of several months or longer. The symptoms of long covid include fatigue or muscle weakness, dyspnea, cognitive impairment, and depression or anxiety. These chronic symptoms can also negatively affect aviation safety. Therefore, this review summarizes studies of the long-term effects of COVID-19, and aeromedical implications of long COVID.

Keywords

COVID-19, Complications, Aviation, Pilot, Aerospace medicine

References

Go to
  1. World Health Organization (WHO). Coronavirus disease (COVID-19): post COVID-19 condition [Internet]. Geneva: WHO; 2021 [cited 2022 Aug 17]. Available from: https://www.who.int/news-room/questions-andanswers/item/coronavirus-disease-(covid-19)-postcovid-19-condition#:~:text=People%20with%20post%20COVID%2D19,as%20work%20or%20household%20chores.
  2. Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021;53:737-754. https://doi.org/10.1080/23744235.2021.1924397
    Pubmed PMC CrossRef
  3. Ayoubkhani D. Prevalence of long COVID symptoms and COVID-19 complications [Internet]. Newport: Office for National Statistics; 2020 [cited 2022 Aug 17]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/datasets/prevalenceoflongcovidsymptomsandcovid19complications.
  4. Crook H, Raza S, Nowell J, Young M, Edison P. Long covid— mechanisms, risk factors, and management. BMJ 2021;374:n1648. https://doi.org/10.1136/bmj.n1648
    Pubmed CrossRef
  5. McFadyen JD, Stevens H, Peter K. The emerging threat of (micro)thrombosis in COVID-19 and its therapeutic implications. Circ Res 2020;127:571-587. https://doi.org/10.1161/CIRCRESAHA.120.317447
    Pubmed PMC CrossRef
  6. Miesbach W, Makris M. COVID-19: coagulopathy, risk of thrombosis, and the rationale for anticoagulation. Clin Appl Thromb Hemost 2020;26:1076029620938149. https://doi.org/10.1177/1076029620938149
    Pubmed PMC CrossRef
  7. Galván-Tejada CE, Herrera-García CF, Godina-González S, Villagrana-Bañuelos KE, Amaro JDL, Herrera-García K, et al. Persistence of COVID-19 symptoms after recovery in Mexican population. Int J Environ Res Public Health 2020;17:9367. https://doi.org/10.3390/ijerph17249367
    Pubmed PMC CrossRef
  8. Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al.; ARC Study Group. 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax 2021;76:396-398. https://doi.org/10.1136/thoraxjnl-2020-215818
    Pubmed PMC CrossRef
  9. Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J 2021;57:2003481. https://doi.org/10.1183/13993003.03481-2020
    Pubmed PMC CrossRef
  10. van den Borst B, Peters JB, Brink M, Schoon Y, Bleeker-Rovers CP, Schers H, et al. Comprehensive health assessment 3 months after recovery from acute coronavirus disease 2019 (COVID-19). Clin Infect Dis 2021;73:e1089-e1098. https://doi.org/10.1093/cid/ciaa1750
    Pubmed PMC CrossRef
  11. Evans PC, Rainger GE, Mason JC, Guzik TJ, Osto E, Stamataki Z, et al. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc Res 2020;116:2177-2184. https://doi.org/10.1093/cvr/cvaa230
    Pubmed PMC CrossRef
  12. Massoomi MR, Anderson RD, Ahmed MM, Dasa O, George P Jr, Miles WM, et al. Cardiovascular considerations for the internist and hospitalist in the COVID-19 era. Am J Med 2020;133:1254-1261. https://doi.org/10.1016/j.amjmed.2020.06.005
    Pubmed PMC CrossRef
  13. Linschoten M, Peters S, van Smeden M, Jewbali LS, Schaap J, Siebelink HM, et al.; CAPACITY-COVID Collaborative Consortium. Cardiac complications in patients hospitalised with COVID-19. Eur Heart J Acute Cardiovasc Care 2020;9:817-823. https://doi.org/10.1177/2048872620974605
    Pubmed PMC CrossRef
  14. Lazaridis C, Vlachogiannis NI, Bakogiannis C, Spyridopoulos I, Stamatelopoulos K, Kanakakis I, et al. Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery. Hellenic J Cardiol 2020;61:381-395. https://doi.org/10.1016/j.hjc.2020.05.004
    Pubmed PMC CrossRef
  15. Sala S, Peretto G, De Luca G, Farina N, Campochiaro C, Tresoldi M, et al. Low prevalence of arrhythmias in clinically stable COVID-19 patients. Pacing Clin Electrophysiol 2020;43:891-893. https://doi.org/10.1111/pace.13987
    Pubmed PMC CrossRef
  16. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061-1069. https://doi.org/10.1001/jama.2020.1585
    Pubmed PMC CrossRef
  17. Wang Y, Wang Z, Tse G, Zhang L, Wan EY, Guo Y, et al. Cardiac arrhythmias in patients with COVID-19. J Arrhythm 2020;36:827-836. https://doi.org/10.1002/joa3.12405
    Pubmed PMC CrossRef
  18. Tomasoni D, Italia L, Adamo M, Inciardi RM, Lombardi CM, Solomon SD, et al. COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease. Eur J Heart Fail 2020;22:957-966. https://doi.org/10.1002/ejhf.1871
    Pubmed PMC CrossRef
  19. Miners S, Kehoe PG, Love S. Cognitive impact of COVID-19: looking beyond the short term. Alzheimers Res Ther 2020;12:170. https://doi.org/10.1186/s13195-020-00744-w
    Pubmed PMC CrossRef
  20. Wang HY, Li XL, Yan ZR, Sun XP, Han J, Zhang BW. Potential neurological symptoms of COVID-19. Ther Adv Neurol Disord 2020;13:1756286420917830. https://doi.org/10.1177/1756286420917830
    Pubmed PMC CrossRef
  21. Najjar S, Najjar A, Chong DJ, Pramanik BK, Kirsch C, Kuzniecky RI, et al. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation 2020;17:231. https://doi.org/10.1186/s12974-020-01896-0
    Pubmed PMC CrossRef
  22. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683-690. https://doi.org/10.1001/jamaneurol.2020.1127
    Pubmed PMC CrossRef
  23. Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T, et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain 2020;143:3104-3120. https://doi.org/10.1093/brain/awaa240
    Pubmed PMC CrossRef
  24. Yachou Y, El Idrissi A, Belapasov V, Ait Benali S. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol Sci 2020;41:2657-2669. https://doi.org/10.1007/s10072-020-04575-3
    Pubmed PMC CrossRef
  25. Valenzano A, Scarinci A, Monda V, Sessa F, Messina A, Monda M, et al. The social brain and emotional contagion: COVID-19 effects. Medicina (Kaunas) 2020;56:640. https://doi.org/10.3390/medicina56120640
    Pubmed PMC CrossRef
  26. Emami A, Fadakar N, Akbari A, Lotfi M, Farazdaghi M, Javanmardi F, et al. Seizure in patients with COVID-19. Neurol Sci 2020;41:3057-3061. https://doi.org/10.1007/s10072-020-04731-9
    Pubmed PMC CrossRef
  27. Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the nervous system. Cell 2020;183:16-27.e1. https://doi.org/10.1016/j.cell.2020.08.028
    Pubmed PMC CrossRef
  28. Jain U. Effect of COVID-19 on the organs. Cureus 2020;12:e9540. https://doi.org/10.7759/cureus.9540
    CrossRef
  29. Asadi-Pooya AA. Seizures associated with coronavirus infections. Seizure 2020;79:49-52. https://doi.org/10.1016/j.seizure.2020.05.005
    Pubmed PMC CrossRef
  30. Ministry of Land, Infrastructure and Transport. Manual of civil aviation medicine. 5th ed. Sejong: Dawon ; 2019.
  31. Ptacek R, Ptackova H, Martin A, Stefano GB. Psychiatric manifestations of COVID-19 and their social significance. Med Sci Monit 2020;26:e930340.
    CrossRef
  32. Chan KS, Zheng JP, Mok YW, Li YM, Liu YN, Chu CM, et al. SARS: prognosis, outcome and sequelae. Respirology 2003;8(Suppl 1):S36-S40. https://doi.org/10.1046/j.1440-1843.2003.00522.x
    Pubmed PMC CrossRef
  33. Mak IW, Chu CM, Pan PC, Yiu MG, Chan VL. Long-term psychiatric morbidities among SARS survivors. Gen Hosp Psychiatry 2009;31:318-326. https://doi.org/10.1016/j.genhosppsych.2009.03.001
    Pubmed PMC CrossRef
  34. Nalleballe K, Reddy Onteddu S, Sharma R, Dandu V, Brown A, Jasti M, et al. Spectrum of neuropsychiatric manifestations in COVID-19. Brain Behav Immun 2020;88:71-74. https://doi.org/10.1016/j.bbi.2020.06.020
    Pubmed PMC CrossRef
  35. Di Minno A, Ambrosino P, Calcaterra I, Di Minno MND. COVID-19 and venous thromboembolism: a meta-analysis of literature studies. Semin Thromb Hemost 2020;46:763-771. https://doi.org/10.1055/s-0040-1715456
    Pubmed PMC CrossRef
  36. Colling ME, Kanthi Y. COVID-19-associated coagulopathy: an exploration of mechanisms. Vasc Med 2020;25:471-478. https://doi.org/10.1177/1358863X20932640
    Pubmed PMC CrossRef
  37. Ko SY, Nguyen NK, Lee CL, Lee LA, Nguyen KUT, Lee EC. Aeromedical implications of long-term COVID-19 sequelae. Aerosp Med Hum Perform 2021;92:898-907. https://doi.org/10.3357/AMHP.5928.2021
    Pubmed CrossRef

Related articles in KJASEM

More Related Articles